|
Successful Treatment of Ascites using a Denver<sup>®</sup> Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome
|
Oct 2016
|
Intern Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2012
|
J Pediatr Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Supportive care in severe and very severe aplastic anemia
|
Dec 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes
|
Dec 2020
|
Hematology/oncology and stem cell therapy
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Syngeneic transplantation in aplastic anemia: pretransplant conditioning and peripheral blood are associated with improved engraftment - an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European
|
Jul 2013
|
Haematologica
|
aplastic anemia
|
|
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways
|
Jun 2017
|
J Immunol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways
|
Jul 2017
|
Journal of Immunology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R
|
Sep 2017
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Targeting the Microenvironment in MDS: The Final Frontier
|
Jul 2020
|
Frontiers in Pharmacology
|
myelodysplastic syndromes (MDS)
|
|
Targeting TP53 Mutations in Myelodysplastic Syndromes
|
Apr 2020
|
Hematology/oncology clinics of North America
|
myelodysplastic syndromes (MDS)
|
